Radiographic imaging of bronchioloalveolar carcinoma: Screening, patterns of presentation and response assessment

Journal of Thoracic Oncology

Volumn 1, Issue 9 SUPPL., 2006, Pages

  Gandara, David R ^a,h   Aberle, Denise ^b   Lau, Derick ^c   Jett, James ^c   Akhurst, Tim ^d   Mulshine, James ^e   Berg, Christine ^f   Patz Jr , Edward F ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GEFITINIB; ANTINEOPLASTIC AGENT;

ADENOMA; CALCULATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HEALTH PROGRAM; HUMAN; IMAGING; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MASS SCREENING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RADIOGRAPHY; SURVIVAL TIME; TREATMENT RESPONSE; COMPARATIVE STUDY; FEMALE; LUNG RESECTION; LUNG TUMOR; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 34247893967     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/s1556-0864(15)30005-8     Document Type: Conference Paper

References (65)

1. Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994;73:1163-1170.
2. Breathnach OS, Ishibe N, Williams J, Linnoila, et al. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer 1999;86:1165-1173.
3. Mornex JF, Thivolet F, De las Heras M, et al. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease. Curr Top Microbiol Immunol 2003;275:225-248.
4. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg 2002;74:1640-1646.
5. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
6. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
7. Sone S, Li F, Yang ZG, et al. Characteristics of small lung concerns invisible on conventional chest radiography and detected by population based screening using spiral CT. Brit J Radiol 2000;73:137-145.
8. Sone S, Li F, Yang Z-G, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001;84:25-32.
9. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association Project. J Clin Oncol 2002;20:911-920.
10. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-513.
11. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using low dose spiral CT. Results of baseline and 1-year follow-up studies. Chest 2002;122:15-20.
12. Bepler G, Carney DG, Djulbegovic B, et al. A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 2003;10:306-314.
13. Gaeta M, Caruso R, Barone M, et al. Ground-glass attenuation in nodular bronchioloalveolar carcinoma: CT patterns and prognostic value. J Comput Assist Tomogr 1988;22:215-219.
14. Lee KS, Kim Y, Han J, et al. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings [Review]. Radiographics 1997;17:1345-1357.
15. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: Histologic characteristics and prognosis. Cancer 1995;75:2844-2852.
16. Kishi K, Homma S, Kurosaki A, et al. Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung Cancer 2004;44:43-51.
17. Nakamura H, Saji H, Ogata A, et al. Lung cancer patient showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2003;44:61-68.
18. Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 2003;75:1601-1606.
19. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002;121:1464-1467.
20. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003;180:817-826.
21. Yang Z-G, Sone S, Takashima S, et al. High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. AJR Am J Roentgenol 2001;176:1399-1407.
22. Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected sub-centimeter lung cancers: a favorable progrnosis for ground glass opacity lesions. Ann Thorac Surg 2003;76:1016-1022.
23. Suzuki K, Yokose T, Yoshida J, et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000;69:893-897.
24. Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 NO MO adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002;124:278-284.
25. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004;28:17-23.
26. Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodules: high-resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469-476.
27. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220:803-809.
28. Travis WD, Colby TV, Corrin B, et al. Histological Typing of Lung and Pleural Tumors: World Health Organization international histological classification of tumors. Berlin: Springer, 1999.
29. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency of part solid and nonsolid nodules. AJR Am J Roentgenol 2002;178:1053-1057.
30. Jett JR, Swensen SJ, Midthun DE, et al. Screening for lung cancer with low-dose spiral computed tomography (SCT): The Mayo Clinic trial. Am J Respir Crit Care Med 2004;169:A752.
31. Read WL, Page NC, Tierney RM, et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.
32. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: The Mayo Program. J Occup Med 1986 28:746-750.
33. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-1316.
34. Usuda K, Saito Y, Sagawa M, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 1994;74:2239-2244.
35. Yankelevitz DF, Kostis WJ, Henschke CI, et al. Overdiagnosis in chest radiographic screening for lung carcinoma: frequency. Cancer 2003;97:1271-1275.
36. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Brit J Radiol 2000;73:1252-1259.
37. Hill CA. Bronchioloalveolar carcinoma: a review. Radiology 1984;150:15-20.
38. Bonomo L, Storto ML, Ciccotosto C. Bronchioloalveolar carcinoma of the lung. Eur Radiology 1998;8:996-1001.
39. Shah RM, Balsara G, Webster M, et al. Bronchioloalveolar cell carcinoma: impact of histology on dominant CT pattern. J Thorac Imag 2000;15:180-186.
40. Im JG, Han MC, Yu EJ, et al. Lobar bronchioloalveolar carcinoma: "angiogram sign" on CT scans. Radiology 1990;176:749-753.
41. Akata S, Fukushima A, Kakizaki D, et al. CT scanning of bronchioloalveolar carcinoma: specific appearances. Lung Cancer 1995;12:221-230.
42. Okada M, Nishio W, Sakamoto T, et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovas Surg 2004;127:857-861.
43. Gaeta M, Barone M, Caruso R, et al. CT-pathologic correlation in nodular bronchioloalveolar carcinoma. J Comput Assist Tomogr 1994;18:229-232.
44. Epstein DM. Bronchioloalveolar carcinoma. Semin Roentgenol 1990;25:105-111.
45. Nagao M, Murase K, Yasuhara Y, et al. Measurement of localized ground-glass attenuation on thin-section computed tomography images: correlation with the progression of bronchioloalveolar carcinoma of the lung. Invest Radiology 2002;37:692-697.
46. Gaeta M, Caruso R, Blandino A, et al. Radiolucencies and cavitation in bronchioloalveolar carcinoma: CT-pathologic correlation. Eur Radiology 1999;9:55-59.
47. Akira M, Atagi S, Kawahara M, et al. High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients. AJR Am J Roentgenol 1999;73:1623-1629.
48. Adler B, Padley S, Miller RR, Muller NL. High-resolution CT of bronchioloalveolar carcinoma. AJR Am J Roentgenol 1992;159:275-277.
49. Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 2000;41:85-92.
50. Yap CS, Schiepers C, Fishbein MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nuc Med Mol Imag 2002;29:1166-1173.
51. Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998;170:935-939.
52. Heyneman LE, Patz, EF Jr., PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 2002;38:261-266.
53. Jeong HJ, Min JJ, Park JM, et al. Determination of hte prognostic value of [(18)F] fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 2002;23:865-870.
54. Marom ER, sarvis S, Herndon JE, et al. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002;223:453-459.
55. Ahuja F, Coleman RE, Herndon J, Patz EF Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung cancer. Cancer 1998;83:918-924.
56. Cheran SK, Nielsen ND, Patz False negative primary lung tumors on FDG-PET imaging: staging and prognostic implications. AJR Am J Roentgenol 2004;182:1129-1132.
57. Miller AB, Hogestraeten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214.
58. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: Unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999;91:523-528.
59. Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver and intraobserver variabilityu in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response. J Clin Oncol 2003;21:2574-2582.
60. Gandara DR, West H, Chansky K, et al. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition. Clin Cancer Res 2004;10:4205-4210.
61. Lau D, West H, Laptalo L, et al. Computer-assisted image analysis of response of bronchioloalveolar carcinoma to ZD1839. Lung Cancer 2003;41:S55.
62. Lau D, Seibert A, Gandara D, Laptalo L, Geraghty E, Coulon C. Computer-assisted image analysis of bronchioloalveolar carcinoma. Clin Lung Cancer 2005;6:281-286.
63. Kelly K, Alencar H, Funovics M, Mahmood U, Weissleder R. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 2004;64:6247-6251.
64. Campa MJ, Serlin SB, Patz EF Jr. Development of novel tumor imaging agents using phage-display combinatorial peptide libraries. Acad Radiol 2002;9:927-932.
65. Campa MJ, Chien-Tsun K, O'Connor-McCourt MD, Bigner DD, Patz EF Jr. Design of a novel small peptide targeted against tumor specific EGFRvIII: potential for molecular tumor imaging. Biochem Biophys Res Commun 2000;275:631-636.